Vascular Access Sheaths

Vascular Access Sheaths Market Outlook

The global vascular access sheaths market is projected to reach USD 1.5 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic diseases that require long-term vascular access, along with technological advancements in sheath materials and designs that enhance patient safety and procedural efficiency. The rise in minimally invasive surgical procedures has also contributed significantly to the demand for vascular access sheaths, as these devices are essential for reducing complications and improving recovery times. Furthermore, the growing geriatric population, who are more susceptible to conditions requiring vascular access, is expected to drive market growth. As healthcare systems worldwide prioritize enhancing patient outcomes, the vascular access sheaths market is poised for substantial growth.

Growth Factor of the Market

The vascular access sheaths market is experiencing a robust growth trajectory primarily due to the rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, which necessitate effective vascular access for treatment. Another factor contributing to market growth is the increasing number of minimally invasive surgeries, where vascular access sheaths play a critical role in facilitating procedures while minimizing patient trauma. Additionally, advancements in medical technology, including the development of antimicrobial sheaths and other specialized devices, are enhancing the safety and effectiveness of vascular access procedures. The evolving healthcare infrastructure, particularly in emerging markets, is further amplifying the demand for these devices as hospitals and clinics upgrade their medical equipment. Furthermore, the growing focus on patient-centered care and improved healthcare outcomes is driving investments in innovative vascular access solutions.

Key Highlights of the Market

• Significant growth driven by rising chronic disease prevalence.
• Technological advancements leading to improved device safety and efficacy.
• Increased demand for minimally invasive surgical techniques.
• Expansion of healthcare infrastructure in emerging markets.
• Growing preference for antimicrobial and specialty sheaths.

By Product Type

Standard Sheaths:

Standard sheaths are widely used in various medical procedures, serving as a reliable option for vascular access. Their versatility and ease of use make them a staple in hospitals and outpatient facilities. These sheaths come in various sizes to accommodate different patients and procedures, ensuring that healthcare providers can find the appropriate sheath for specific clinical scenarios. The standardization of these products has led to lower costs and increased accessibility, further driving their adoption. Innovations in design and material have improved their performance, leading to reduced complications during procedures. Overall, the standard sheath segment remains a significant contributor to the vascular access sheaths market due to its fundamental role in medical practice.

Split Sheaths:

Split sheaths offer unique advantages in terms of flexibility and ease of access, making them a preferred choice for complex vascular procedures. These devices enable clinicians to perform simultaneous interventions without needing to remove the sheath, which is crucial during intricate surgeries. Split sheaths are particularly popular in instances where multiple accesses are necessary, allowing for a streamlined procedural workflow. The ongoing development of split sheath technologies aims to enhance their safety and reduce the risk of complications. As the demand for more efficient surgical procedures rises, the split sheath segment is expected to experience significant growth, driven by its operational benefits in challenging clinical situations.

Hemostatic Sheaths:

Hemostatic sheaths play a vital role in managing bleeding during and after vascular access procedures. These specialized sheaths incorporate advanced mechanisms to reduce blood loss, thereby enhancing patient safety and recovery times. The increasing emphasis on patient-centered care is driving the adoption of hemostatic sheaths, as they contribute to better clinical outcomes and decreased complications. Manufacturers are continuously improving the design and functionality of these sheaths, with a focus on user-friendliness and ease of integration into existing medical practices. The growth of the hemostatic sheath segment is expected to align with the broader trend of improving surgical efficacy and patient safety in vascular procedures.

Antimicrobial Sheaths:

Antimicrobial sheaths are gaining traction in the vascular access sheaths market due to their ability to minimize the risk of infections associated with vascular access. These devices are coated with antimicrobial agents that help prevent bacterial colonization, which is a significant concern in patients requiring prolonged vascular access. The increasing awareness of the importance of infection control in healthcare settings is fueling the demand for antimicrobial sheaths, particularly in high-risk patients. As healthcare providers continue to prioritize patient safety, the antimicrobial sheath segment is expected to experience robust growth, supported by ongoing research and development aimed at enhancing the efficacy of antimicrobial coatings.

Specialty Sheaths:

Specialty sheaths are tailored for specific medical applications, providing solutions for complex procedures that require unique features not found in standard sheaths. This segment includes devices designed for cardiology, oncology, and neurology, among others, catering to the specialized needs of these fields. The growth of specialty sheaths is driven by advancements in medical technology and a deeper understanding of the unique requirements of various procedures. As the healthcare landscape evolves and more procedures demand specialized solutions, the specialty sheath segment is poised to expand, offering innovative products that enhance clinical efficacy and patient outcomes.

By Application

Cardiovascular Procedures:

In the context of cardiovascular procedures, vascular access sheaths are indispensable for enabling interventions such as angioplasty, stenting, and catheterization. These procedures often require reliable vascular access points to ensure successful outcomes while minimizing complications. The increasing prevalence of cardiovascular diseases globally has heightened the demand for effective vascular access solutions in this sector. As healthcare providers adopt more advanced techniques in cardiology, the reliance on vascular access sheaths is expected to grow correspondingly, supporting a larger market share within this application segment. Moreover, the continuous development of minimally invasive cardiovascular procedures is projected to drive further innovation in sheath design and functionality.

Dialysis:

Dialysis remains a significant application for vascular access sheaths, particularly for patients suffering from chronic kidney disease. These sheaths facilitate hemodialysis and peritoneal dialysis by providing a reliable access point for blood filtration. With the rising prevalence of kidney diseases and an aging population, the demand for efficient dialysis solutions is increasing markedly. The advancements in dialysis technologies, combined with the growing awareness of the importance of vascular access, are expected to further enhance the market for vascular access sheaths in this application. As healthcare systems focus on improving patient outcomes and quality of life for those with kidney ailments, the dialysis application segment will likely see a steady increase in adoption rates of specialized vascular access sheaths.

Oncology:

In the oncology field, vascular access sheaths play a critical role in administering chemotherapy and other therapeutic agents. Patients undergoing cancer treatment often require long-term vascular access to manage their care effectively. The rise in cancer incidence worldwide is driving demand for reliable and safe vascular access solutions. Specialty vascular access sheaths designed for oncology applications are evolving to enhance patient comfort and minimize complications associated with prolonged access. This focus on patient-centered care in oncology is expected to result in significant growth for this segment as healthcare providers seek to improve the overall treatment experience for cancer patients.

Neurovascular Procedures:

Neurovascular procedures, including endovascular surgeries for conditions such as aneurysms and arterial occlusions, require specialized vascular access sheaths that can navigate the intricate vascular pathways of the brain. These procedures are often complex and demand high precision, which makes the choice of vascular access sheath critical. The increasing prevalence of neurological disorders is boosting the demand for effective solutions in this area. As advancements in neurovascular technology continue, there will likely be a corresponding increase in the development and use of specialized vascular access sheaths designed for these intricate procedures, thereby expanding the market's footprint in this application segment.

Others:

Other applications of vascular access sheaths fall within a broad spectrum, including gastroenterology, urology, and emergency medicine. The versatility of these sheaths makes them suitable for various procedures across multiple medical disciplines. As healthcare providers seek to enhance patient care and improve procedural outcomes, the adoption of vascular access sheaths in these diverse applications is expected to rise. The growing emphasis on integrated healthcare solutions and advancements in medical technologies will continue to drive the need for reliable vascular access devices across various specialties, contributing to the overall expansion of the market.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for vascular access sheaths, given their critical role in surgical and interventional procedures. These facilities invest heavily in advanced medical technologies and equipment to enhance patient care and outcomes. The increasing number of surgeries performed in hospitals, particularly minimally invasive and outpatient procedures, has driven the demand for vascular access sheaths. Hospitals often stock a wide range of products to cater to various surgical specialties, ensuring that clinicians have access to the latest innovations. As healthcare systems continue to evolve and expand, the hospital distribution channel is projected to maintain a strong market presence, supported by increasing healthcare expenditures worldwide.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly popular for performing outpatient surgical procedures, contributing to the growth of the vascular access sheaths market. These centers focus on providing high-quality care in a cost-effective manner, and their rise in popularity is driven by the demand for minimally invasive procedures that allow for quicker recovery times. ASCs are equipped to handle various surgical specialties, and the need for effective vascular access solutions is paramount in these settings. As the trend towards outpatient surgery continues to grow, the ASC distribution channel is expected to play a significant role in driving the demand for vascular access sheaths.

Specialty Clinics:

Specialty clinics that focus on specific medical fields such as oncology, nephrology, and cardiology are increasingly important distribution channels for vascular access sheaths. These clinics cater to patients with unique healthcare needs, and their focus on specialized care drives the demand for tailored vascular access solutions. As the healthcare industry shifts towards more personalized care models, specialty clinics are likely to see an uptick in the use of vascular access sheaths designed for their specific patient populations. This trend underscores the importance of targeted marketing and product development in the vascular access sheaths market, ensuring that healthcare providers have the necessary tools to deliver quality care.

Online Sales:

The online sales channel for vascular access sheaths is gaining momentum due to the increasing digitization of healthcare and the growing trend of e-commerce. Online platforms provide healthcare professionals with easy access to a wide variety of products, often at competitive prices. The convenience of ordering medical supplies through digital channels is appealing to many healthcare providers, particularly smaller clinics and practices with limited budgets. As the shift towards online sales continues to grow, manufacturers and distributors are investing in e-commerce strategies to reach a broader audience. This trend is expected to enhance market accessibility and drive sales in the vascular access sheaths sector.

By Material Type

Polyurethane Sheaths:

Polyurethane sheaths are widely utilized in vascular access applications due to their excellent biocompatibility and flexibility. These materials are known for their durability and ability to withstand various procedural demands, making them suitable for a range of clinical scenarios. The inherent properties of polyurethane, such as low friction and reduced risk of thrombosis, enhance patient comfort and safety, which are crucial in long-term vascular access situations. As healthcare providers increasingly prioritize materials that minimize complications, the demand for polyurethane sheaths is expected to grow, driven by both procedural requirements and patient safety concerns.

Nylon Sheaths:

Nylon sheaths are another popular choice in the vascular access sheaths market, owing to their strength and reliability. These materials offer excellent tensile strength and resistance to kinking, ensuring that the sheath maintains its integrity during procedures. Nylon is also relatively lightweight, making it user-friendly for healthcare professionals. The combination of these properties contributes to the growing preference for nylon sheaths in various medical settings, particularly in emergency and critical care situations where rapid access is essential. As the demand for robust and reliable medical devices increases, the nylon sheath segment is positioned for continued growth within the market.

PTFE Sheaths:

PTFE (Polytetrafluoroethylene) sheaths are recognized for their exceptional non-stick properties and low friction, making them ideal for vascular access applications. These sheaths are particularly effective in minimizing complications such as thrombosis, which is a significant concern in long-term vascular access scenarios. The chemical resistance of PTFE also contributes to its popularity, as it can withstand a variety of fluids without degrading. As healthcare providers increasingly focus on reducing the risk of complications associated with vascular access, the demand for PTFE sheaths is expected to rise, bolstered by ongoing advancements in material science.

Silicone Sheaths:

Silicone sheaths are favored for their biocompatibility and soft texture, which enhances patient comfort during vascular access procedures. The flexibility of silicone materials allows for easy manipulation and positioning, making them suitable for diverse medical applications. Silicone's resistance to degradation and ability to maintain performance over time are critical factors driving their use in long-term vascular access scenarios. As the healthcare industry continues to evolve towards patient-centric approaches, the demand for silicone sheaths is anticipated to grow, particularly among populations requiring prolonged access.

Others:

Other materials used in the production of vascular access sheaths may include thermoplastics and composite materials that combine the favorable properties of different substances. These materials are continuously being developed to enhance the performance, safety, and comfort of vascular access devices. The ongoing exploration of novel materials aims to address specific challenges within vascular access procedures, such as minimizing complications and improving patient experience. As research and innovation continue in this field, the segment of 'others' is expected to expand, contributing to the overall growth of the vascular access sheaths market.

By Region

The North American vascular access sheaths market is expected to dominate due to the advanced healthcare infrastructure, high prevalence of chronic diseases, and increasing number of surgical procedures performed. The region accounted for approximately 35% of the global market share in 2023. With a CAGR of 8.0% projected through 2035, North America is likely to lead the market, driven by continuous innovations in medical technology and a robust investment in healthcare systems. The presence of key market players and a growing emphasis on patient safety and infection control further bolster the region's market growth. Moreover, the rising geriatric population in North America is expected to create additional demand for vascular access sheaths in the coming years.

In Europe, the vascular access sheaths market is projected to follow closely behind North America, accounting for around 28% of the global market share. With a CAGR of 6.5% from 2025 to 2035, Europe's growth is fueled by an increasing focus on improving healthcare services and patient outcomes. Governments and healthcare institutions are investing more in advanced medical technologies and procedures, which directly impacts the demand for vascular access sheaths. The aging population across Europe, along with the rise in chronic diseases, further contributes to the expected growth in this region. The favorable regulatory environment and reimbursement policies will also play a crucial role in advancing the market in Europe.

Opportunities

There are significant opportunities within the vascular access sheaths market, particularly in emerging economies where healthcare infrastructure is undergoing rapid development. As countries invest in upgrading their medical facilities and adopting advanced technologies, there is a strong demand for innovative medical devices, including vascular access sheaths. These markets present an opportunity for manufacturers to introduce tailored products that meet the unique needs of local healthcare systems, which often differ from those in developed nations. Collaborations with local distributors and healthcare providers can facilitate market entry and expansion, enabling companies to tap into the vast potential of these regions. Furthermore, the growing emphasis on preventative healthcare and the management of chronic diseases in these markets presents a chance for developing specialized vascular access solutions.

Additionally, the ongoing advancements in materials and technology are opening new avenues for innovation within the vascular access sheaths market. Manufacturers can explore new materials that enhance safety, such as bioresorbable polymers, which could reduce the long-term complications associated with traditional sheaths. The integration of smart technology, such as sensors and monitoring capabilities, into vascular access sheaths could revolutionize patient care by providing real-time data to healthcare providers. This focus on innovation not only enhances patient outcomes but also positions companies at the forefront of the market, allowing them to capture additional market share and establish a competitive advantage in a rapidly evolving landscape.

Threats

Despite the robust growth prospects of the vascular access sheaths market, several threats could impede its expansion. One significant challenge is the increasing regulatory scrutiny surrounding medical devices, which has become more stringent in recent years. Manufacturers must navigate complex regulatory frameworks to ensure compliance with safety and efficacy standards before their products can enter the market. This process can be time-consuming and costly, potentially delaying product launches and market entry. Additionally, the risk of product recalls due to adverse events or quality issues poses a threat to manufacturers, as it can lead to reputational damage and financial losses.

Another threat facing the vascular access sheaths market is the growing competition from alternative access methods and devices. As healthcare providers continually seek more efficient and cost-effective solutions, new technologies may emerge that could replace traditional vascular access sheaths. For instance, the rise of implantable ports and other advanced access devices may shift market dynamics and challenge the dominance of vascular access sheaths. To remain competitive, manufacturers must focus on innovation and differentiation, ensuring their products meet the evolving needs of healthcare providers and patients.

Competitor Outlook

• Bard Medical
• Boston Scientific
• Medtronic
• Terumo Corporation
• Teleflex Incorporated
• Cook Medical
• Smiths Medical
• AngioDynamics
• Vascular Solutions, Inc.
• Abbott Laboratories
• Halyard Health
• Johnson & Johnson
• 3M Healthcare
• Fresenius Medical Care
• ConvaTec Group PLC

The competitive landscape of the vascular access sheaths market is characterized by a mix of established players and emerging companies, each vying for market share through a combination of innovation, strategic partnerships, and acquisition strategies. Key players in the market focus on developing advanced vascular access products that address specific clinical needs, ensuring patient safety and procedural efficacy. The market is witnessing a surge in collaborations among healthcare providers, manufacturers, and research institutions to enhance product development and expand the range of vascular access solutions available. This collaborative approach not only fosters innovation but also helps in navigating regulatory challenges, ensuring timely market entry for new products.

Major companies, such as Bard Medical and Boston Scientific, are leveraging their extensive research and development capabilities to launch innovative vascular access sheaths that meet the changing demands of healthcare providers. For instance, Bard Medical has introduced a range of hemostatic sheaths designed to minimize bleeding during procedures, while Boston Scientific focuses on antimicrobial solutions to reduce the risk of infection. Medtronic and Terumo Corporation are also key players investing in advanced technologies that improve the performance and safety of vascular access devices. As these companies continue to innovate and expand their product portfolios, competition in the vascular access sheaths market is expected to intensify.

Furthermore, the emergence of small and medium-sized enterprises (SMEs) is contributing to the dynamic nature of the market. These companies often focus on niche segments and innovative solutions that cater to specific healthcare needs. They are agile and responsive to market trends, allowing them to capture opportunities that larger players may overlook. As a result, the vascular access sheaths market is becoming increasingly fragmented, with a diverse range of products and solutions available to healthcare providers. This fragmentation presents both challenges and opportunities, as companies must continually adapt to changing market conditions and evolving customer demands to remain competitive.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Bard Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 3M Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 AngioDynamics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Halyard Health
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smiths Medical
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Boston Scientific
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Johnson & Johnson
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 ConvaTec Group PLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Terumo Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Abbott Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teleflex Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fresenius Medical Care
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Vascular Solutions, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Vascular Access Sheaths Market, By Application
    • 6.1.1 Cardiovascular Procedures
    • 6.1.2 Dialysis
    • 6.1.3 Oncology
    • 6.1.4 Neurovascular Procedures
    • 6.1.5 Others
  • 6.2 Vascular Access Sheaths Market, By Product Type
    • 6.2.1 Standard Sheaths
    • 6.2.2 Split Sheaths
    • 6.2.3 Hemostatic Sheaths
    • 6.2.4 Antimicrobial Sheaths
    • 6.2.5 Specialty Sheaths
  • 6.3 Vascular Access Sheaths Market, By Material Type
    • 6.3.1 Polyurethane Sheaths
    • 6.3.2 Nylon Sheaths
    • 6.3.3 PTFE Sheaths
    • 6.3.4 Silicone Sheaths
    • 6.3.5 Others
  • 6.4 Vascular Access Sheaths Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Vascular Access Sheaths Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Vascular Access Sheaths market is categorized based on

By Product Type

• Standard Sheaths
• Split Sheaths
• Hemostatic Sheaths
• Antimicrobial Sheaths
• Specialty Sheaths

By Application

• Cardiovascular Procedures
• Dialysis
• Oncology
• Neurovascular Procedures
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Sales

By Material Type

• Polyurethane Sheaths
• Nylon Sheaths
• PTFE Sheaths
• Silicone Sheaths
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Bard Medical
• Boston Scientific
• Medtronic
• Terumo Corporation
• Teleflex Incorporated
• Cook Medical
• Smiths Medical
• AngioDynamics
• Vascular Solutions, Inc.
• Abbott Laboratories
• Halyard Health
• Johnson & Johnson
• 3M Healthcare
• Fresenius Medical Care
• ConvaTec Group PLC